Pete Gillis

Statistics

Publications

Citations

242

H-Index

Active since

2015

Affiliations

Kindeva Drug Delivery (United States)(Current)

Pete Gillis is an author at Kindeva Drug Delivery (United States) specializing in immunology, tumor microenvironment modulation, and tumor microenvironment effects.

Publications per year

2015–2019

Publications

Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies

Stefanie Mullins, John P. Vasilakos, Katharina Deschler et al. · Journal for ImmunoTherapy of Cancer · 2019 · 204 citations · Full text

Life Sciences, Immunology, Oncology +17

Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality

Elizabeth C. Swanson, Pete Gillis, Nelmary Hernandez-Alvarado et al. · Vaccine · 2015 · 38 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

1–2 of 2